Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Neuroprotective Effect of a Novel Soluble Guanylate Cyclase Activator Runcaciguat in Diabetic and Ischemic Retinopathy

Diabetes(2025)10.2337/db24-0739Source: DataRank Database

Neuroprotective Effect of a Novel Soluble Guanylate Cyclase Activator Runcaciguat in Diabetic and Ischemic Retinopathy is a research paper published in Diabetes (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.03)OA: greenTopics (44)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Zhenhua Xu ORCID,Hongkwan Cho ORCID,S.X. Wu,William Schubert,Carsten Terjung ORCID

Live enrichment

PubMed:40249725 OpenAlex:https://openalex.org/W4409601976

NIH

Grant: EY022383 and EY035549 and P30EY0017675

NEI NIH HHS

Grant: P30 EY001765

NEI NIH HHS

Grant: R01 EY035549

NEI NIH HHS

Grant: R01 EY022383

Bayer AG

FWCI

1.03

Citation Percentile

0.7%

Citation Trend

2026

greenLicense: https://www.diabetesjournals.org/journals/pages/license

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12185964/

publisherhttps://diabetesjournals.org/diabetes/article-pdf/74/7/1220/804893/db240739.pdf

journalhttps://doi.org/10.2337/db24-0739

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40249725

Fields of Study

Retinal Diseases and TreatmentsRetinal Development and DisordersRetinopathy of Prematurity StudiesAnimalsDiabetic RetinopathyHumansSoluble Guanylyl CyclaseRatsNeuroprotective AgentsDiabetes Mellitus, ExperimentalRetinaMaleOxidative StressRats, Sprague-DawleyBiphenyl CompoundsCyclopropanes

MeSH Terms

Soluble Guanylyl CyclaseAnimalsBiphenyl CompoundsCyclopropanesDiabetes Mellitus, ExperimentalDiabetic RetinopathyHumansMaleRetinaRats, Sprague-DawleyOxidative StressNeuroprotective AgentsRats

Keywords

RetinaNeuroprotectionOxidative stressRetinalDiabetic retinopathyElectroretinographyActivator (genetics)MedicineDiabetes mellitusBiologyNeuroscienceCell biologyEndocrinologyInternal medicineOphthalmology

Sustainable Development Goals

SDG 0: Good health and well-being